Research Section
Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays

https://doi.org/10.1016/S0278-6915(98)00101-XGet rights and content

Abstract

Phytosterols are natural constituents of the human diet, and as part of an extensive programme of safety evaluation studies investigating their use as a novel food ingredient, the possible oestrogenic effects of phytosterols have been investigated using a combination of in vitro and in vivo assays. Competitive binding with the immature rat uterine oestrogen receptor (ER) has been used to measure the ability of phytosterols to bind to ERs while the transcriptional activation of oestrogen-responsive genes has been examined in an oestrogen-inducible yeast screen. Phytosterols did not display any activity in these in vitro assays. Uterotrophic assays have been conducted to investigate the potential for phytosterols to elicit an oestrogenic response when administered orally to immature female rats (n=10) at doses of 0, 5, 50 or 500 mg/kg/day for 3 consecutive days. Phytosterols (a well characterized mixture of β-sitosterol, campesterol and stigmasterol) and phytosterol esters (the previous phytosterol mixture esterified with fatty acids from sunflower oil) did not exhibit oestrogenic activity in the immature female rat using uterine wet weight as the endpoint. β-oestradiol (0.4 mg/kg/day) consistently produced a significant increase in uterus weights. Coumestrol (a known phytoestrogen) was also tested as a weak positive control and produced a dose response at doses of 20, 40 and 80 mg/kg/day in the uterotrophic assay. In conclusion, we have shown that phytosterols do not bind to the ER and do not stimulate transcriptional activity of the human ER in a recombinant yeast strain. In addition, there was no indication of oestrogenicity from the uterotrophic assay when the material was administered by oral gavage to immature female rats.

Introduction

Phytosterols, or plant sterols, are natural constituents of the human diet and are commonly found as minor constituents (0.1–0.5%, w/w) of edible vegetable oils (Kochhar, 1983). They are structurally related to cholesterol, but differ in their side-chain configuration (Fig. 1). There is a wide variety of phytosterol structures but the most frequent phytosterols found in nature are β-sitosterol, campesterol and stigmasterol which occur in the free form or esterified to free fatty acids, sugar moieties or phenolic acids. Dietary intake of phytosterols in northern European countries has been estimated to be 200–300 mg/day (Morton et al., 1995), with intakes in vegetarians and Japanese estimated to be higher (300–450 mg/day) (Nair et al., 1984; Nakashima et al., 1981).

Phytosterols esterified with fatty acids from sunflower oil, referred to as phytosterol esters (PE), are being investigated for use as a novel food ingredient, primarily for use in margarine and spreads as a functional component with blood cholesterol-lowering properties. Esterification is important to increase their solubility in the oil phase of the spread.

A number of reports in the literature have suggested that phytosterols may have effects on the reproductive system, and in particular that they possess oestrogenic activity (Elghamry and Hensel, 1969; Malini and Vanithakumari, 1993; Mellanen et al., 1996; Rosenblum et al., 1993; Samannoudy et al., 1980). However, many of these studies were not designed in a way appropriate for assessing the potential hazard of materials intended for oral consumption, and in addition, crude plant extracts were often used and purity of individual phytosterols not specified.

Therefore, as part of an extensive programme of safety evaluation studies, the oestrogenic potential of phytosterols (a well characterized mixture of β-sitosterol, campesterol and stigmasterol) was assessed using a combination of in vitro and in vivo assays. The first assay, competitive binding with the oestrogen receptor (ER), uses a cell-free system to determine the extent to which the compound binds to the ER, as reflected by its ability to displace 3H-oestradiol from the ER (Ireland et al., 1980). Secondly, the transcriptional activation of oestrogen responsive genes has been examined in an oestrogen-inducible yeast screen (Routledge and Sumpter, 1996). This assay employs a yeast strain (Saccharomyces cerevisiae) transfected with human ER and an oestrogen-responsive element (ERE) linked to the reporter gene lac-Z (encoding the enzyme β-galactosidase). Thus, in the presence of an oestrogenic compound, β-galactosidase is synthesized and secreted into the medium, where it is detected as a colorimetric change. The third assay was used to determine the effects of phytosterols on an oestrogen-responsive tissue in an intact animal. The immature rat uterotrophic assay (Wakeling et al., 1991), one of the most widely used methods to detect oestrogenicity, was used to determine whether oral exposure to phytosterols led to increased uterine weight. Therefore, by providing information on three levels of hormonal activity, an informative profile of oestrogenic potential could be obtained.

Section snippets

Chemicals

β-oestradiol (E2), diethylstilbestrol (DES), cholesterol and cholesteryl palmitate were obtained from Sigma (Poole, Dorset, UK). [2,4,5,6-3H]oestradiol (3H-E2) was obtained from Amersham (Little Chalfont, Buckinghamshire, UK). β-Sitosterol (purity by gas chromatography >99%) was obtained from Sigma. Coumestrol [purity by gas chromatography–mass spectrometry (GC–MS) >99%] was obtained from Apin Chemicals Ltd (Abingdon, Oxfordshire, UK). Phytosterols, analysed by GC–MS as a mixture of β

Results

Results from the in vitro competitive ER binding assay, the recombinant yeast screen and the in vivo uterotrophic assay are presented. β-Estradiol was included as a positive control in all the studies to monitor and ensure the performance of the test systems and to provide reference data against which to compare the results of the other test substances. In addition coumestrol, a coumestan with known oestrogenic activity (Gaido et al., 1996; Markaverich et al., 1995; Odum et al., 1997; Whitten

Discussion

Reports in the literature have suggested that phytosterols may have effects on the reproductive system and in particular that they possess oestrogenic activity (Elghamry and Hensel, 1969; Malini and Vanithakumari 1993; Mellanen et al., 1996; Rosenblum et al., 1993; Samannoudy et al., 1980). As part of an extensive programme of safety evaluation studies, the oestrogenic potential of phytosterols was assessed using a combination of in vitro and in vivo assays.

A study by Rosenblum et al. (1993)

Acknowledgements

The authors would like to thank Dr Ed Routledge for performing some of the yeast assays.

References (27)

  • P.L. Whitten et al.

    Effects of phytoestrogen diet on estrogen-dependent reproductive processes in immature female rats

    Steroids

    (1992)
  • M.I. Elghamry et al.

    Activity and isolated phytoestrogen of shrub palmetto fruits (Serenoa repens small), a new estrogenic plant

    Experientia

    (1969)
  • K.W. Gaido et al.

    Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay

    Toxicology and Applied Pharmacology

    (1996)
  • Cited by (117)

    • Cytotoxic and antimicrobial activities of new phytosteroids from the leaves of Anonidium mannii (Oliv.) Engl. & Diels (Annonaceae)

      2022, South African Journal of Botany
      Citation Excerpt :

      As shown in Table 6, AM1C and AM2C possess best activity against M. tuberculosis with MIC90 s of 39.4 and 46.6 and MIC90 s of 47.6 and 107 µg/mL, respectively. Phytosteroids are a group of naturally occurring compounds found in plants with chemical structures close to those of cholesterol, the only difference being in their side-chain configuration or extra double bond (Baker et al., 1999). They have proven beneficial biological effects like lowering serum cholesterol levels, cytotoxic, and antimicrobial activities (Mubiu et al., 2017).

    • Determination of estrogenic activity in the river Chienti (Marche Region, Italy) by using in vivo and in vitro bioassays

      2016, Journal of Environmental Sciences (China)
      Citation Excerpt :

      In most cases, the estrogenic effect of a mixture of chemicals and their degraded products may result in different biological potency with respect to the effects related to a single contaminant exposure (Krein et al., 2012). Current strategies for monitoring estrogens are based on the use of a battery of in vivo and in vitro ecotoxicological tests (Baker et al., 1999a,b, 2000; Fasulo et al., 2010; Isidori et al., 2010; Palermo et al., 2008; Reel et al., 1996; Shelby et al., 1996). In particular, mechanism based-in vitro tests (e.g. ER binding dependent transcriptional activity) are used as first step screening tools, prior to moving into in vivo assays (OECD, 2003).

    • Identification of beta-sitosterol and stigmasterol in Bambusa bambos (L.) Voss leaf extract using HPLC and its estrogenic effect in vitro

      2015, Journal of Pharmaceutical and Biomedical Analysis
      Citation Excerpt :

      But there were increase in cell proliferation when compared to the control (Fig. 6). Phytosterols especially β-sitosterol has been proved to be not estrogenic itself but needs to be metabolized to a hormonally active metabolite [29]. Evaluation of the estrogen-agonistic effects of HEBB extract was done at various concentrations under estrogen-deprived conditions.

    View all citing articles on Scopus
    View full text